These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15571214)

  • 1. Pharmacokinetics/pharmacodynamics of Y-700, a novel xanthine oxidase inhibitor, in rats and man.
    Yamada I; Fukunari A; Osajima T; Kamezawa M; Mori H; Iwane J
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1123-5. PubMed ID: 15571214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion.
    Fukunari A; Okamoto K; Nishino T; Eger BT; Pai EF; Kamezawa M; Yamada I; Kato N
    J Pharmacol Exp Ther; 2004 Nov; 311(2):519-28. PubMed ID: 15190124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
    Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
    J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice.
    Kong LD; Yang C; Ge F; Wang HD; Guo YS
    J Ethnopharmacol; 2004 Aug; 93(2-3):325-30. PubMed ID: 15234772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity.
    Kong L; Zhou J; Wen Y; Li J; Cheng CH
    Planta Med; 2002 Feb; 68(2):175-8. PubMed ID: 11859475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers.
    Becker MA; Kisicki J; Khosravan R; Wu J; Mulford D; Hunt B; MacDonald P; Joseph-Ridge N
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1111-6. PubMed ID: 15571211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
    Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.
    Khosravan R; Kukulka MJ; Wu JT; Joseph-Ridge N; Vernillet L
    J Clin Pharmacol; 2008 Sep; 48(9):1014-24. PubMed ID: 18635756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors.
    Ishibuchi S; Morimoto H; Oe T; Ikebe T; Inoue H; Fukunari A; Kamezawa M; Yamada I; Naka Y
    Bioorg Med Chem Lett; 2001 Apr; 11(7):879-82. PubMed ID: 11294382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats.
    Liu X; Chen R; Shang Y; Jiao B; Huang C
    Chem Biol Interact; 2008 Nov; 176(2-3):137-42. PubMed ID: 18694741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor.
    Niu Y; Zhu H; Liu J; Fan H; Sun L; Lu W; Liu X; Li L
    Chem Biol Interact; 2011 Feb; 189(3):161-6. PubMed ID: 21167141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia.
    Khanna S; Burudkar S; Bajaj K; Shah P; Keche A; Ghosh U; Desai A; Srivastava A; Kulkarni-Almeida A; Deshmukh NJ; Dixit A; Brahma MK; Bahirat U; Doshi L; Nemmani KV; Tannu P; Damre A; B-Rao C; Sharma R; Sivaramakrishnan H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7543-6. PubMed ID: 23122864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
    Lü JM; Yao Q; Chen C
    Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids of Cynara scolymus possess potent xanthinoxidase inhibitory activity in vitro but are devoid of hypouricemic effects in rats after oral application.
    Sarawek S; Feistel B; Pischel I; Butterweck V
    Planta Med; 2008 Feb; 74(3):221-7. PubMed ID: 18300193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dual actions of morin (3,5,7,2',4'-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity.
    Yu Z; Fong WP; Cheng CH
    J Pharmacol Exp Ther; 2006 Jan; 316(1):169-75. PubMed ID: 16169936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia.
    Komoriya K; Hoshide S; Takeda K; Kobayashi H; Kubo J; Tsuchimoto M; Nakachi T; Yamanaka H; Kamatani N
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1119-22. PubMed ID: 15571213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects.
    Yoon S; Shin D; Lee H; Jang IJ; Yu KS
    Drug Des Devel Ther; 2015; 9():5033-49. PubMed ID: 26357467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
    Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity.
    Niu Y; Liu J; Liu HY; Gao LH; Feng GH; Liu X; Li L
    Pharm Biol; 2016 Sep; 54(9):1680-6. PubMed ID: 26916555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.